Corteva
Develops seed genetics and crop-protection products for farmers worldwide.
Something off on this page? Send us feedback.
Profile
Develops seed genetics and crop-protection products, earning revenue from seed and trait sales, licensing, herbicides, insecticides, fungicides and biologicals worldwide. A planned separation would spin Seed into Vylor and leave CTVA focused on Crop Protection.
Develops commercial seed and crop-protection products through two operating segments. Seed combines proprietary germplasm and traits for corn, soybeans, canola, cotton, sunflower and other crops, marketed through brands including Pioneer, Brevant and PhytoGen and through trait licensing. Crop Protection supplies herbicides, insecticides, fungicides, biologicals and nitrogen stabilizers, including Enlist, Arylex, Rinskor and Zorvec technologies.
Pairs genetics and chemistry research with direct farmer relationships, distributors and region-specific seed routes to market across North America, Latin America, Europe, the Middle East, Africa and Asia-Pacific. Demand and sales timing follow planting seasons, acreage, crop prices and weather, while commercialization depends on regulatory approvals and intellectual-property rights. A planned October separation would spin Seed into Vylor, leaving the CTVA-listed business focused on Crop Protection.
Company facts
Key statistics
Year to date +23.9% · Average volume (30d) 4.5M
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Rating | Prior target | Target |
|---|---|---|---|---|---|
| Aug 3, 2026 | Deutsche Bank | Reiterate | Buy | $65 | $101 |
| Aug 3, 2026 | BMO Capital | Reiterate | Outperform | $86 | $100 |
| Jul 21, 2026 | RBC Capital | Reiterate | Outperform | $95 | $103 |
| Jul 14, 2026 | Mizuho Securities | Target | $96 | $97 | |
| Jul 2, 2026 | Mizuho Securities | Target | $82 | $96 |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Jul 30, 2026Q2 FY26 | $2.24 | $2.30 | +2.7% | $6.60B | $6.38B | −3.3% | −11.90% |
| May 5, 2026Q1 FY26 | $1.17 | $1.50 | +28.2% | $4.64B | $4.91B | +5.7% | −2.54% |
| Feb 3, 2026Q4 FY25 | $0.22 | $0.22 | −1.3% | $4.24B | $3.91B | −7.8% | +0.11% |
| Nov 4, 2025Q3 FY25 | −$0.51 | −$0.23 | +54.6% | $2.47B | $2.62B | +6.0% | +1.87% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $4.42B | $6.46B | $2.62B | $3.91B | $4.91B | $6.38B | |
| Gross profit | $2.08B | $3.52B | $974.0M | $1.66B | $2.53B | $3.47B | |
| Operating income | $827.0M | $1.83B | −$270.0M | $242.0M | $1.16B | $1.92B | |
| Net income | $652.0M | $1.31B | −$320.0M | −$552.0M | $720.0M | $1.16B | |
| Diluted EPS | $0.95 | $1.92 | −$0.47 | −$0.82 | $1.07 | $1.73 | |
| Gross margin | 47.0% | 54.6% | 37.2% | 42.4% | 51.6% | 54.4% | |
| Operating margin | 18.7% | 28.4% | -10.3% | 6.2% | 23.5% | 30.0% |
Fiscal years (4-quarter sums)FY21 $15.66B · FY22 $17.46B · FY23 $17.23B · FY24 $16.91B · FY25 $17.40B
Revenue by product · Q2 FY26
Revenue by geography · Q2 FY26
Balance sheet, Jun 30, 2026Cash & short-term investments $2.37B · Total debt $4.88B · Total assets $41.64B · Shareholders' equity $25.16B
Dividends
Raised for 5 straight years — most recently to $0.18 from $0.17 in Sep 2025. To collect a payout, hold shares through the close before the ex-date.
History
| Ex-date | Record | Paid | Amount | Note |
|---|---|---|---|---|
| Jun 1, 2026 | Jun 1 | Jun 15 | $0.18 | |
| Mar 2, 2026 | Mar 2 | Mar 16 | $0.18 | |
| Dec 1, 2025 | Dec 1 | Dec 15 | $0.18 | |
| Sep 2, 2025 | Sep 2 | Sep 15 | $0.18 | raised from $0.17 |
| Jun 2, 2025 | Jun 2 | Jun 16 | $0.17 | |
| Mar 3, 2025 | Mar 3 | Mar 17 | $0.17 | |
| Dec 2, 2024 | Dec 2 | Dec 16 | $0.17 | |
| Sep 3, 2024 | Sep 3 | Sep 17 | $0.17 | raised from $0.16 |
Ownership
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 668.82M · Float 667.84M · 99.9% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 53.85M | 8.05% | 13F | Aug 7, 2026 |
| Vanguard Capital Management LLC | 43.79M | 6.55% | 13F | Aug 13, 2026 |
| Capital World Investors | 42.92M | 6.42% | 13F | Aug 12, 2026 |
| FMR LLC | 41.07M | 6.14% | 13F | Aug 13, 2026 |
| State Street Corp | 38.26M | 5.72% | 13F | Aug 7, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Feb 20, 2026 | Brian Titus | officer: See Remarks | −8,311 | $76.55 |
| Aug 29, 2025 | Robert D. King | officer: EVP, Crop Protection Business | −37,280 | $74.20 |
Peers
- FMC
Pure-play crop protection; diamide insecticide leader in head-to-head contest.
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Corteva | $83.90 | −0.04% | $56.11B | 55.6 | 21.4 | 3.2 | −1.2% |
| FMC | $11.32 | 0.00% | $1.42B | — | 8.0 | 0.4 | −17.5% |
| Median | — | 8.0 | 0.4 | −17.5% |